作者
Jeanne M Regnante, Nicole A Richie, Lola Fashoyin-Aje, Michelle Vichnin, Marvella Ford, Upal Basu Roy, Kenneth Turner, Laura Lee Hall, Evelyn Gonzalez, Nestor Esnaola, Luther T Clark, Homer C Adams III, Olatunji B Alese, Keerthi Gogineni, Lorna McNeill, Daniel Petereit, Ify Sargeant, Julie Dang, Coleman Obasaju, Quita Highsmith, Simon Craddock Lee, Spencer C Hoover, Erin L Williams, Moon S Chen Jr
发表日期
2019/4
期刊
Journal of oncology practice
卷号
15
期号
4
页码范围
e289-e299
出版商
American Society of Clinical Oncology
简介
PURPOSE
Participation of racial and ethnic minority groups (REMGs) in cancer trials is disproportionately low despite a high prevalence of certain cancers in REMG populations. We aimed to identify notable practices used by leading US cancer centers that facilitate REMG participation in cancer trials.
METHODS
The National Minority Quality Forum and Sustainable Healthy Communities Diverse Cancer Communities Working Group developed criteria by which to identify eligible US cancer centers—REMGs comprise 10% or more of the catchment area; a 10% to 50% yearly accrual rate of REMGs in cancer trials; and the presence of formal community outreach and diversity enrollment programs. Cancer center leaders were interviewed to ascertain notable practices that facilitate REMG accrual in clinical trials.
RESULTS
Eight cancer centers that met the Communities Working Group criteria were invited to participate in …
学术搜索中的文章
JM Regnante, NA Richie, L Fashoyin-Aje, M Vichnin… - Journal of oncology practice, 2019